Spots Global Cancer Trial Database for Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
Official Title: Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Risk
Study ID: NCT00839696
Conditions
Interventions
Study Description
Brief Summary: Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.
Detailed Description:
Keywords
Eligibility
Minimum Age: 55 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Wisconsin Hospital, Madison, Wisconsin, United States
Contact Details
Name: Amy Trentham Dietz, PhD
Affiliation: Associate Professor- Population Health Sciences, UW School of Medicine and Public Health
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
